Association Between Prostate Cancer and Myocardial Infarction Management and Postinfarction Outcomes: A Norwegian...

Area of Science:

• Cardiology
• Oncology
• Public Health

Background:

• Prostate cancer (PCa) is common in Norway, and cardiovascular disease (CVD), including acute myocardial infarction (AMI), is a leading cause of death in PCa survivors.
• Shared risk factors and PCa treatments can increase CVD risk, necessitating comparative outcome analysis.

Purpose of the Study:

• To compare outcomes after AMI in men with PCa versus the general male population.
• To evaluate differences in invasive management, complications, cardiovascular events, reinfarction, and secondary prevention post-AMI.

Main Methods:

• Utilized nationwide registry data from Norway for men aged 40-85 experiencing their first AMI between 2013-2019.
• Compared outcomes between men with localized PCa (diagnosed 2004-2019) and the general AMI population using logistic and Cox regression.

Main Results:

• Of 34,362 AMI patients, 1405 (4.1%) had PCa. No significant differences in invasive management or secondary medical treatment were observed.
• PCa patients had lower overall in-hospital complications (OR 0.77) but higher serious bleeding risk (OR 1.66).
• Major adverse cardiovascular events and reinfarction rates were similar; one-year survival was better for PCa patients (HR 0.82).

Conclusions:

• Standard AMI treatment protocols are applicable to localized PCa patients.
• Close monitoring for bleeding risk is crucial in PCa patients experiencing AMI.